Novartis India (BOM:500672) FFO


BOM:500672 Novartis India Ltd BOM:500672
65 GF Score
Price ₹1,469.15
GF Value ₹927.96
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Novartis India FFO?

FFO (Funds from operations) only applies to REITs.

BOM:500672
65GF Score
Novartis India Ltd BOM:500672
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Novartis India (BOM:500672) Overvalued in 2026?

Based on GuruFocus' analysis, Novartis India stock appears to be overvalued. The current stock price of ₹1,469.15 is trading 58.3% above its estimated GF Value™ of ₹927.96. GuruFocus considers Novartis India to be Significantly Overvalued.

Key valuation signals for BOM:500672:

  • FFO:
  • GF Value™: ₹927.96 vs. price of ₹1,469.15 (58.3% above fair value)
  • GF Score™: 65/100 with 7 warning signs

No single metric tells the full story. See the BOM:500672 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Novartis India Business Description

Other Exchanges NOVARTIND:India
Address Inspire BKC, Part of 601 & 701, Bandra Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Novartis India Ltd is an Indian-based pharmaceutical company. The company is engaged in the trading of Drugs and Pharmaceuticals. It derives revenue from operations in India. The company operates in a single business segment, namely Pharmaceutical Business. Its Pharmaceutical business focuses on Bone and Pain, Transplantation Immunology, and Neurosciences.
65GF Score

Get the complete analysis for BOM:500672

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,469.15
Price
₹927.96
GF Value